On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- Passing Screening to Smart Toilets: The Potential of Digital Bowel Movement Biomarkers (GI Insights)
- What you need to know before Digestive Disease Week® (DDW) 2024 (AGA)
- Test-at-home kit for cancer patients approved for use (BBC)
- Oregon Physician Assistants Get Name Change (Medscape)
- Arizona Digestive Health Expands Services with New Physicians in Scottsdale (GlobeNewsWire)
- SAGES announces 2024 ‘Shark Tank’ winner (Becker’s GI & Endoscopy)
- A Sneak Peek at Digestive Disease Week 2024 (GI Insights)
- ‘A Simple Idea That Could Make a Substantial Impact’: Can a String Replace Endoscopies for Esophageal Cancer, Other Disorders? (University of Colorado)